CORV
REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
12/07/2025
Back to search
Official data from USPTO
IMMUNOGLOBE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
IMMUNOGLOBE
ST13
US500000086230340Class
1, 42
Filing
86230340
Registration
4631973
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/08/2025
Classification
Registered
Trademark type
Word
Nice classes
1, 42
Filing date
03/24/2014
Registration date
11/04/2014
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2020
Last transaction
12/08/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
04/01/1997
First use in commerce
09/03/1997
Drawing code
4
Owner type
16
Owner location
Himmelstadt, DE
Examiner
DIXON,JENNIFER HAZARD
Law office
M10
Current location
TMO LAW OFFICE 110
Holders and representatives
Holders
immunoGlobe Antikoerpertechnik GmbH
Representatives
Cecelia M. Perry McGlew and Tuttle, P.C.
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemicalsmonoclonal antibodies for in vitro scientific or research use; Biochemicalspolypeptides for in vitro research use; Biological tissueseraother blood constituentsas well as human and animal tissue lysates for use in scientific and medical research; Chemical reagents for non-medical purposesfor use in evaluating antibodies directed against an antigen of interest; Diagnostic preparations for scientific or research use; Diagnostic reagents for scientific or research use; Laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Protein in raw material form for scientific and medical research; Reagents for research purposes
Class 42
Biochemical research and development; Biotechnology research; Custom design and development of chemical reagents and biochemical assays; Development of new technology for others in the field of antibody technologyprotein biochemistrybiotechnology; Laboratory research in the field of antibody technologyprotein biochemistrybiotechnology; Product development in the field of antibody technologyprotein biochemistrybiotechnology; Product research and development; Providing scientific information in the field of antibody technologyprotein biochemistrybiotechnology; Research and development and consultation related thereto in the field of antibody technologyprotein biochemistrybiotechnology; Research and development of new products; Research and development of new products for others; Scientific and technological servicesscientific researchdesigndevelopment and production of customized reagents and antibodies in the field of antibody technologyprotein biochemistrybiotechnology; Scientific laboratory services; Scientific research in the field of antibody technologyprotein biochemistrybiotechnology
Publications
History of USPTO decisions and trademark events.
25 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/07/2025
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/04/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
11/01/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/04/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/17/2020
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/17/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/17/2020
ES8R
TEAS SECTION 8 RECEIVED
11/04/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/04/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/19/2014
PUBO
PUBLISHED FOR OPPOSITION
08/19/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/30/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/15/2014
ALIE
ASSIGNED TO LIE
07/14/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/26/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
06/26/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/26/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
06/26/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/26/2014
DOCK
ASSIGNED TO EXAMINER
06/25/2014
MPMK
NOTICE OF PSEUDO MARK E-MAILED
04/08/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/05/2014
NWAP
NEW APPLICATION ENTERED
03/27/2014
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOGLOBE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.